Wockhardt Ltd :

1683.80 -61.15 [-3.50%]

ISIN: INE049B01025 | NSE: WOCKPHARMA | Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln | BSE Code: 532300 | Comments

Price Information
• Open	1755.00
• High	1765.00
• Low	1675.00
• Previous Close	1744.95
• Shares Traded	39464
• 52 Wk High Price	2166.05
• 52 Wk High Date	12-03-2013
• 52 Wk Low Price	631.00
• 52 Wk Low Date	22-05-2012
• Face Value	5.00

Fundamentals
• Market Capital (Rs.cr)	19705.80
• EPS (Rs.)(TTM)	18.21
• P/E Ratio(TTM)	98.76
• Book Value (Rs.)	11.00
• Price to Book Value	163.46
• Equity (Rs.cr.)	54.79
• Traded Value (Rs.lac)	777.33

Index Names
• BSE-500

Related Companies
Stock Name	Price

CIPLA	417.10
JBCHEPHARM	83.90
JAYANTVITAMINS	3.00	-
MERIND	200.00	-
PIRHEALTH	569.20
RANBAXY	436.35
UNICHEMLAB	179.45
ALEMBICLTD	19.70
LYKALABS	9.47
TTKHEALTH	514.25

Share Tips for Wockhardt Ltd

Commodity Stock Tips Free Trial >> Vis (10:33AM, May 21 '13)

Pharma Stocks Outlook for the week (11 (02:05PM, Feb 09 '13)

Buy Wockhardt Ltd above 1258.00, targe (04:06PM, Sep 26 '12)

God Morning Shares to watch:- Tata Mot (09:48AM, Sep 18 '12)

Wockhardt Ltd is a BUY call with a tar (09:52AM, Sep 11 '12)

Key Financials	Latest Qrtr.	Trailing Yr.	Full Yr.
• Year End	Dec, 2012	Dec, 2012	Mar, 2012
• Sales (Rs.cr)	554.83	2599.57	2560.40
• Net Profit (Rs.cr)	53.71	199.50	259.66
• Net Profit Var (%)	-54.00	-41.00	61.00
• EPS (Rs)	-	18.21	23.70
• P/E Ratio	-	98.76	75.90
• Operating Profit Margin	-	25.08	-
• CPS (Rs.)	-	-	29.80
• P/C Ratio	-	-	60.40
• Div%	-	-	-

Announcements
25-01-2013	Wockhardt allots equity shares
21-02-2011	Wockhardt and Sheffield Bio-Science, USA announce a strategic alliance
27-07-2012	Wockhardt divests its Nutrition Business to Danone
06-12-2011	Wockhardt gets UK MHRA nod for Clarithromycin tablets
28-06-2012	Wockhardt grants stock options
09-08-2011	Wockhardt issues stock options
08-01-2013	Wockhardt launches generic version of anti-convulsant drug Lamictal XR Received final approval from
17-09-2012	Wockhardt launches generic version of anti-ulcer drug Prevacid
10-01-2012	Wockhardt launches generic version of Rhinitis drug Flonase nasal spray
28-09-2012	Wockhardt received tentative approval for Pregablin capsules
08-07-2011	Wockhardt received tentative approval for the Dulexotine Hydrochloride
01-07-2011	Wockhardt receives approval for generic version of Patanol ophthalmic solution
15-07-2011	Wockhardt receives final approval for the generic Lunesta
01-12-2012	Wockhardt redeems 208,555,274 OCCRPS-1
27-12-2012	Wockhardt To Allot Equity Shares
05-08-2011	Wockhardt to announce financial results
02-02-2012	Wockhardt to announce Q3 results
12-11-2011	Wockhardt to grant 15,40,000 stock options
14-05-2013	Wockhardt To hold Board Meeting
22-08-2012	Wockhardt to launch generic version of anti-hypertensive drug Plendil
14-08-2012	Wockhardt to launch generic version of BPH drug Uroxatral
17-08-2012	Wockhardt to launch generic version of clot-buster drug Plavix

Gross Deliverables

Date Del. Shares Trd. Qty. Del.(%) Del. Value Turnover

20-05-2013 14399 32258 44.64 25125535 57049.50
17-05-2013 21086 42813 49.25 37918954 77732.90
13-05-2013 21179 61678 34.34 36649201 107503.00
11-05-2013 6148 21159 29.06 10689835 36735.30
10-05-2013 37783 102395 36.90 63299749 173474.00

Note:

- % change is w.r.t. Prev. Close
- On ex-date % change is w.r.t. open price
- On the date ofmovement of security from/to trade for trade segment, % change is w.r.t. open price
- 52 week high & 52 week low prices are based on the trade date & not adjusted with corporate action

Comment(s) posted on Wockhardt Ltd

Hot Searches • plas • onelife • bhagwatiho • fiber • sunphar • tatasteel • pfizer • areva • ranbaxy • icicibank

Date	Del. Shares	Trd. Qty.	Del.(%)	Del. Value	Turnover
20-05-2013	14399	32258	44.64	25125535	57049.50
17-05-2013	21086	42813	49.25	37918954	77732.90
13-05-2013	21179	61678	34.34	36649201	107503.00
11-05-2013	6148	21159	29.06	10689835	36735.30
10-05-2013	37783	102395	36.90	63299749	173474.00